Updated results including quality of life of the phase III CAIRO3 study of the Dutch Colorectal Cancer Group (DCCG): Maintenance treatment with capecitabine and bevacizumab versus observation after induction treatment with chemotherapy and bevacizumab in metastatic colorectal cancer (mCRC)
EUROPEAN JOURNAL OF CANCER(2013)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要